Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 21 Jun 21 424B4 Prospectus supplement with pricing info
- 18 Jun 21 EFFECT Notice of effectiveness
- 15 Jun 21 S-1/A IPO registration (amended)
- 11 Jun 21 S-1/A IPO registration (amended)
- 8 Jun 21 S-1/A IPO registration (amended)
- 4 Jun 21 S-1/A IPO registration (amended)
- 26 May 21 S-1/A IPO registration (amended)
-
20 Apr 21 S-1 IPO registration
ATAI similar filings
Filing view
External links
Exhibit 99.1
Consent of Director Nominee
ATAI Life Sciences B.V. is filing a Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the initial public offering of common shares of ATAI Life Sciences B.V. In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of ATAI Life Sciences B.V. in the Registration Statement, as may be amended from time to time. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
/s/ Michael Auerbach |
Name: Michael Auerbach |
Date: April 20, 2021